UK'S GOLDEN TRIANGLE PARTNERSHIP (GTP) SIGNS MEMORANDUM OF UNDERSTANDING WITH MASSBIO TO PROMOTE BIOTECH INDUSTRY
Organisations Commit to Facilitate Cross-ocean Investment and Partnering
London-October 23, 2009-The Golden Triangle Partnership, a joint collaboration between the three primary life sciences and healthcare networking organisations in Oxford, London and Cambridge, today announced it has signed a Memorandum of Understanding (MOU) with the Massachusetts Biotech Council (MassBio) to cooperatively encourage and promote the biotechnology industry in both regions.
"The Golden Triangle Partnership serves several thousand companies in the UK by providing members a networking platform that brings the life sciences community together to support partnering and collaboration in the industry," said Tony Jones, Director of the London Biotechnology Network.
The MOU outlines the organisation's commitment to facilitate cross-ocean investment and partnering by encouraging collaborations between each group's member companies. Additionally, GTP and MassBio will promote each other's investment and partnering events to their respective members, as well as offer their members reduced rates to each other's signature events.
"This MOU signifies an important step we are taking to extend our network globally with the intention to increase deal flow with Massachusetts companies and investors by facilitating introductions and presenting opportunities," commented ERBI Chief Executive Harriet Fear. "We are delighted with the positive feedback from our members and the Massachusetts life sciences community regarding this historic initiative," added Jon Ress, Chief Executive of OBN.
"This is a significant partnership that brings together the trade groups for two of the world's largest life sciences clusters," said Robert Coughlin, President & CEO of MassBio. "The UK is a recognized leader in drug discovery and development, and we are pleased to offer our members opportunities to collaborate and partner with some of UK's premier life sciences companies."
About the Golden Triangle Partnership
The Golden Triangle Partnership is a collaborative effort between ERBI, Oxford Bioscience Network (OBN) and London Biotechnology Network (LBN), to provide members with potential international partners and investors. The GTP serves companies in the densest region in Europe for therapeutics, medtech, diagnostics and healthcare R & D companies.
About the London Biotechnology Network
The London Biotechnology Network (LBN) is a business network of over 800 organisations/2500 members from the biopharmaceutical industry, academia, investors and professional services with an interest in doing business in, with or through London. LBN strives to provide members with relevant information and networking opportunities to cultivate the right environment for innovation and collaboration in the life sciences community. LBN hosts the excellent annual Genesis networking conference in London.
About the Oxford Bioscience Network
OBN is a not-for-profit biotech business network which exists to catalyse the growth and development of the Oxford and South-East biotech super-cluster. Its activities can be summarised as networking, partnering, group purchasing, and showcasing our cluster. OBN was established in April 30, 1999. OBN hosts the excellent annual BioTrinity Biopartnering and Investment Conference in Oxford.
ERBI is a self-financing, non-governmental, membership based company serving the life sciences and healthcare communities in Cambridge, East of England and further afield. Its activities can be summarised as networking, partnering, purchasing, facilities management, training, HR and business development. ERBI was established in 1997. ERBI hosts the excellent annual BioPartnering Exchange in Cambridge.
About the Massachusetts Biotechnology Council
The Massachusetts Biotechnology Council (MassBio), a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services. For more information, please visit www.massbio.org.
About the UK Healthcare Market
The UK healthcare market was valued at £120 billion in 2006. It is the world's fifth-largest pharmaceuticals market and its National Health Service (NHS) is one of the largest purchasers of medicines; £10.6 billion in 2004. It is home to many of the world's leading clinicians, scientists and researchers. They are attracted by a world-class research and development infrastructure and a track record of bringing cutting edge technologies and products to market.
18 of the world's current top 100 medicines were discovered and developed in the UK. All of the world's top ten pharmaceutical companies have a significant presence in the UK. Many have located substantial research and development and manufacturing operations within the UK. It is second, only to the US, as the world's key life science and healthcare investment destination, attracting 26 percent of all pharmaceutical research and development investment in Europe.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.